Biomind Labs Statistics

Total Valuation

Biomind Labs has a market cap or net worth of 54.30 million. The enterprise value is 55.17 million.

Market Cap	54.30M
Enterprise Value	55.17M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Biomind Labs has 77.57 million shares outstanding. The number of shares has increased by 0.91% in one year.

Current Share Class	n/a
Shares Outstanding	77.57M
Shares Change (YoY)	+0.91%
Shares Change (QoQ)	+3.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-35.67
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-78.28
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-238.02%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	26.44%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +536.36% in the last 52 weeks. The beta is 0.34, so Biomind Labs's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+536.36%
50-Day Moving Average	0.70
200-Day Moving Average	0.47
Relative Strength Index (RSI)	97.79
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-402,455
Pretax Income	-704,799
Net Income	-704,799
EBITDA	-404,225
EBIT	-402,455
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 10,117 in cash and 883,233 in debt, giving a net cash position of -873,116 or -0.01 per share.

Cash & Cash Equivalents	10,117
Total Debt	883,233
Net Cash	-873,116
Net Cash Per Share	-0.01
Equity (Book Value)	-1.52M
Book Value Per Share	-0.02
Working Capital	-1.54M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-461,808
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomind Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.91%
Shareholder Yield	-0.91%
Earnings Yield	-1.30%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a